RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) plus PTX in the treatment of metastatic gastroesophageal junction and gastric adenocarcinoma (mGC) following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy—Efficacy analysis in Japanese and Western patients.

Abstract

4005 Background: RAINBOW, a global phase III trial, demonstrated significant improvements in overall survival (OS), progression-free survival (PFS), and objective response rate (ORR) in patients (p...